Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells for the Induction of Remission in Ulcerative Colitis
Phase 1
- Conditions
- Ulcerative Colitis
- Interventions
- Drug: Allogeneic adipose tissue-derived mesenchymal stem cells
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2013-08-02
- Target Recruit Count
- 8
- Registration Number
- NCT01914887
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Treatment CLI Nonrevascularizable Lower Limb With Cell Therapy
Phase 1
Completed
- Conditions
- Nonrevascularizable Critical Ischemia of the Lower Limbs
- Interventions
- Other: Intramuscular injection of a suspension of adult mesenchymal stem cells derived
- First Posted Date
- 2013-04-04
- Last Posted Date
- 2016-06-15
- Target Recruit Count
- 10
- Registration Number
- NCT01824069
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Stem Cells Treatment for Bilateral Limbic Associated Keratopathy (HULPOFT)
Phase 2
- Conditions
- Keratopathy
- Interventions
- Drug: Expanded adipose-derived stem cells
- First Posted Date
- 2013-03-11
- Last Posted Date
- 2013-03-11
- Target Recruit Count
- 8
- Registration Number
- NCT01808378
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Stem Cells Tratment for the Local Feminine Stress Urinary Incontinence Treatment (HULPURO)
Phase 1
- Conditions
- Urinary Incontinence
- Interventions
- Drug: Adipose-derived expanded stem cells
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2013-03-05
- Target Recruit Count
- 10
- Registration Number
- NCT01804153
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Stem Cells Treatment for the Local Urinary Incontinence After a Radical Prostate Cancer Surgery (HULPURO)
Phase 2
Completed
- Conditions
- Urinary Incontinence
- Interventions
- Drug: Inject of Autologous Adipose-derived stem cells
- First Posted Date
- 2013-02-27
- Last Posted Date
- 2013-03-08
- Target Recruit Count
- 10
- Registration Number
- NCT01799694
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Health Benefits of Functional Oil (Mega 3 Fatty Acids From Fish Oil) on Obese People
Phase 4
Completed
- Conditions
- Obesity
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: functional oil
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2012-12-04
- Target Recruit Count
- 52
- Registration Number
- NCT01739998
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
Phase 2
Completed
- Conditions
- Ischemic Stroke
- Interventions
- Drug: PlaceboDrug: Allogenic mesenchymal stem cells from adipose tissue
- First Posted Date
- 2012-09-05
- Last Posted Date
- 2018-02-28
- Target Recruit Count
- 19
- Registration Number
- NCT01678534
- Locations
- 🇪🇸
University Hospital La Paz, Madrid, Spain
Specific Oral Tolerance Induction in Children Allergic to Cow's Milk Proteins
Not Applicable
Completed
- Conditions
- Cow's Milk Protein Sensitivity
- Interventions
- Other: Cow's milk
- First Posted Date
- 2012-07-17
- Last Posted Date
- 2012-07-17
- Target Recruit Count
- 55
- Registration Number
- NCT01641731
- Locations
- 🇪🇸
Servicio de Alergia Infantil, Hospital Universitario La Paz, Madrid, Spain
Stem Cells Treatment for Extremely Complex Fistulae (HULPCIR)
Phase 2
- Conditions
- Extremely Complex Perianal Fistulae
- Interventions
- Drug: Adipose-derived stem cells without expanded
- First Posted Date
- 2012-04-27
- Last Posted Date
- 2012-04-27
- Target Recruit Count
- 10
- Registration Number
- NCT01586715
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
Stromal Vascular Fraction (SVF) for Treatment of Enterocutaneous Fistula (HULPUTC)
Phase 1
- Conditions
- Enterocutaneous Fistula
- Interventions
- Drug: Adipose-derived stem cells without expanded
- First Posted Date
- 2012-04-25
- Last Posted Date
- 2012-04-25
- Target Recruit Count
- 10
- Registration Number
- NCT01584713
- Locations
- 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
© Copyright 2025. All Rights Reserved by MedPath